Literature DB >> 3194878

Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.

D Honeybourne1, J M Andrews, J P Ashby, R Lodwick, R Wise.   

Abstract

The concentrations of two antibiotics, amoxycillin and ciprofloxacin, were measured by microbiological assay in serum and in bronchial mucosa obtained at fibreoptic bronchoscopy in 38 patients undergoing diagnostic bronchoscopy for a range of respiratory symptoms. Patients had taken one of the two drugs orally for four days before bronchoscopy. The percentage penetration of antibiotic from serum to bronchial mucosa was calculated as the ratio of drug concentration in bronchial tissue to that in serum x 100. Of the nine patients who took amoxycillin 500 mg thrice daily the mean (SD) percentage penetration was 75. This was significantly lower than the mean percentage penetration of 147 in 29 patients who took ciprofloxacin 500 mg twice daily. Ten patients were given a single intravenous dose of ciprofloxacin 200 mg one hour before bronchoscopy and the mean percentage penetration was 231. This study has shown that the quinolone antibiotic ciprofloxacin is concentrated in the bronchial mucosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3194878      PMCID: PMC461461          DOI: 10.1136/thx.43.9.715

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  The mucosal epithelium of the respiratory tract in muco-purulent bronchitis caused by Haemophilus influenzae.

Authors:  J F HERS; J MULDER
Journal:  J Pathol Bacteriol       Date:  1953-07

2.  Distribution of gentamicin and amikacin in rabbit tissues.

Authors:  M L Kornguth; C M Kunin
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Ampicillin levels in sputum, serum, and saliva.

Authors:  S M Stewart; M Fisher; J E Young; W Lutz
Journal:  Thorax       Date:  1970-05       Impact factor: 9.139

4.  Influence of lipophilic character on the antibacterial activity of cephalosporins and penicillins.

Authors:  G L Biagi; M C Guerra; A M Barbaro; M F Gamba
Journal:  J Med Chem       Date:  1970-05       Impact factor: 7.446

Review 5.  Penetration of ciprofloxacin into gynecologic tissues.

Authors:  A Dalhoff; H Weuta
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Serum and sputum levels of cefaclor.

Authors:  C Simon; U Gatzemeier
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

7.  Penetration of cefaclor into bronchial mucosa.

Authors:  G E Marlin; A J Nicholls; G R Funnell; R Bradbury
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

8.  Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.

Authors:  C M Wollschlager; S Raoof; F A Khan; J J Guarneri; V LaBombardi; Q Afzal
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

9.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

10.  The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

Authors:  A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

View more
  16 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

3.  Quantitative morphology and water distribution of bronchial biopsy samples.

Authors:  D R Baldwin; R Wise; J M Andrews; D Honeybourne
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

4.  Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage form.

Authors:  M Saïdna; E M Ouriemchi; J M Vergnaud
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

5.  Concentrations of oral lomefloxacin in serum and bronchial mucosa.

Authors:  D R Baldwin; D Honeybourne; J M Andrews; J P Ashby; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

Authors:  D R Baldwin; J M Andrews; J P Ashby; R Wise; D Honeybourne
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

7.  The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.

Authors:  M Dan; K Torossian; D Weissberg; R Kitzes
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.

Authors:  A Dalhoff
Journal:  Drugs       Date:  1995       Impact factor: 9.546

9.  Antibiotic penetration into lung tissues.

Authors:  D Honeybourne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

10.  Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.

Authors:  I M Gould; G Harvey; D Golder; T M Reid; S J Watt; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.